OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
September 01, 2016
Evonik’s parenteral drug delivery and commercial drug product manufacturing in Alabama passes EU GMP inspection.
The agreement comprises technology transfer and commercial manufacturing of Tillotts’ gastroenterology products.
August 25, 2016
Recipharm is investing EUR3.7 million (approximately $4.18 million) to increase lyophilization capacity at its Masate facility in Italy.
August 24, 2016
AMRI entered into a non-exclusive license agreement with the Broad Institute for the use of CRISPR-Cas9 gene-editing technology.
August 18, 2016
Fresenius Kabi will add to its generic, sterile injectable manufacturing at its Melrose Park, Illinois site.
August 16, 2016
Piramal Enterprises has entered into an agreement to acquire 100% stake in Ash Stevens all by cash for a consideration of $42.95 million plus an earn-out consideration capped at $10 million.
August 15, 2016
Agilent Technologies announces plans to build a new oligo manufacturing facility in Colorado that will double current capacity.
Quebec, Canada-based contract development and manufacturing organization has joined the Pharma & Biopharma Outsourcing Association.
August 11, 2016
The Claristep filtration system from Sartorius improves preparation of samples for analytical testing.
August 04, 2016
The manufacturing subsidiary of Astellas Pharma in Oklahoma has been transferred to CMO Avara and renamed Avara Pharmaceutical Technologies.